Sedation for Paediatric MRI

Evaluation of varying doses of propofol infusion after low dose ketamine for ambulatory paediatric magnetic resonance imaging.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/09/004031

Enrollment

100

Registered

2013-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- children belonging to ASA status 1/2 undergoing MRI for diagnostic or therapeutic purpose

Interventions

Intervention1: Group A: 100mcg/kg propofol infusion Group B: 75 mcg/kg/min propofol infusion Group C: 50 mcg/kg/min propofol infusion : Children will be given propofol infusion as per the allotted gro

Eligibility

Inclusion criteria

Inclusion criteria: ASA status 1 or2 patients in age gp 6 mths to 10 yrs for elective MRI

Exclusion criteria

Exclusion criteria: ASA status 3 or above, severe cardiovascular or pulmonary pathology; documented allergy or intolerance to propofol ; anatomical anomaly of airway; tonsillar hypertrophy grade 3 or above; MRI for acute trauma.

Design outcomes

Primary

Measure	Time frame
Discharge TimeTimepoint: Time in minutes after stopping propofol infusion till patient meets discharge criteria	—

Secondary

Measure	Time frame
need for additional propofol boluses, hemodynamic parameters, scan quality, awakening time and sedation related adverse eventsTimepoint: During scan : Need for additionl bolus, hemodynamic variables, adverse events Afer Scan completion: Scan Quality, awakening time	—

Countries

India

Contacts

Public ContactDIVYA SETHI

Employees State Cooperation Hospital Postgraduate Institute of Medical Sciences and Research

divyasth@gmail.com9891230700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026